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Background/purpose Persistent hyperinsulinemic
hypoglycemia of infancy (PHHI) is the most common cause
of persistent hypoglycemia in infancy with consequences
such as seizures and brain damage. Treatment that
prevents the occurrence of these sequele is essential.
When medical therapy fails or complications are
anticipated, early pancreatectomy is recommended to
maintain euglycemia. The aim of this study was short-term
evaluation of near-total pancreatectomy for PHHI after
failure of medical treatment in patients in Mansoura, Egypt.
Patients and methods During May 2002 to May 2010,
33 patients suffering from persistent hyperinsulinemic
hypoglycemia were admitted to Mansoura university child
hospital. Twenty patients responded to medical treatment
and 13 patients (eight girls and five boys) were treated by
near-total (90–95%) pancreatectomy after failure of
medical treatment. Their ages at the time of surgery ranged
from 20 days to 27 months. Only patients who were
surgically managed were included in this study. All of them
suffered from symptoms of PHHI: thermoregulatory
problems in five cases, tremors in five cases, seizures in
three, irritability in five, respiratory distress in eight, apnea
in four, hypotonia in four, lethargy in five, and feeding
difficulty in four cases. All cases were diagnosed following
strict criteria that included bouts of hypoglycemia without
acidosis coinciding with increased insulin level. Follow-up
ranged from 3 months to 8 years.
Results Primary success occurred in two cases (15%);
four more cases (31%) developed temporary diabetes
mellitus, and one case (8%) had a temporary pancreatic
fistula. Eventually, total cure occurred in seven cases
(54%); six cases (46%) developed a variety of
complications; and persistent hypoglycemia was seen
in two. Persistent diabetes mellitus was observed in three
patients, developmental delay in one, and persistent
neurological deficit in two patients; there was one case
of mortality.
Conclusion Near-total (90–95%) pancreatectomy is a
suitable procedure for treatment of nesidioblastosis not
responding to medical treatment and should be performed
as early as possible. Ann Pediatr Surg 8:49–53 c 2012
Annals of Pediatric Surgery.
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Introduction
Persistent hyperinsulinemic hypoglycemia of infancy
(PHHI) is the most common cause of recurrent and per-
sistent hypoglycemia in infancy and childhood. Causes
include PHHI, pancreatic islet cell tumors such as
insulinoma, and associations with multiple endocrine
neoplasia syndromes. Although new, improved imaging
techniques have allowed for more precise preoperative
localization of insulinomas, the differentiation of nesidio-
blastosis and insulinoma, particularly in children, can be
challenging [1].
Congenital hyperinsulinism of infancy (CHI) is biochem-
ically characterized by the dysregulated secretion of
insulin from pancreatic b-cells. It is a major cause of
persistent hyperinsulinemic hypoglycemia in newborns
and infants. Histologically, there are three major subtypes
of CHI: diffuse, focal, and atypical forms. The diffuse
form is inherited in an autosomal recessive (or dominant)
manner; the focal form is sporadic in inheritance. The
diffuse form of the disease may require a near-total
pancreatectomy, whereas the focal form requires limited
pancreatectomy [2,3].
The focal form represented 40–70% of all cases in one
of the largest series published [4,5]. The focal lesion is
characterized by adenomatous islet cell hyperplasia due
to somatic loss of the maternal chromosome 11p15 region
within a limited region of the pancreas [6]. Endocrine
hyperplasia and excessive b-cell proliferation within the
focal lesion is due to loss of expression of maternally
expressed tumor suppressor genes p57KIP2 and H19 and
upregulation of the paternally expressed IGF-2 gene [7,8].
The adenomatous hyperplasia alone is not sufficient to
cause hypoglycemia; the patient also has to carry a
paternally inherited recessive SUR1 (ABCC8) or Kir6.2
(KCNJ11) mutation. Because of the maternal loss of
heterozygosity, the mutation is able to cause dysregulated
insulin secretion [9,10].
Distinction between the two histopathological forms is
clinically important as near-total pancreatectomy carries a
high risk of iatrogenic diabetes, whereas patients with
focal CHI can be completely cured by a limited resection
of the hyperfunctional tissue [11]. Until now, differential
diagnosis before surgery has been difficult. Invasive and
technically demanding techniques based on pancreatic
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venous sampling or pancreatic arterial calcium stimula-
tion have been used [5,12]. Although found useful in
many cases in some centers, these methods have not
been widely accepted or implemented.
Diazoxide is the first line of treatment for patients with
PHHI. Diazoxide and somatostatin (octreotide) are the
mainstays of medical treatment for the condition. Also,
successful therapy with nifedipine has been documen-
ted [13,14].
PHHI is treated surgically in many centers (near-total
and partial pancreatectomy for diffuse and focal disease,
respectively). Some of the patients treated with near-
total pancreatectomy developed diabetes during child-
hood/puberty [15].
PHHI patients are at increased risk for neurodevelop-
mental disorders, some being severe, which were reported
to occur in 14–44% of patients from highly heterogenous
cohorts. A more conservative approach is now possible
since the separation of the disease into a nonrecurring
focal form, which is cured by partial surgery, and a diffuse
form, which necessitates total pancreatic removal only in
cases of medical treatment failure [16].
The aim of this study was to conduct a short-term evalu-
ation of near-total pancreatectomy for PHHI in patients
in Mansoura, Egypt, after failure of medical treatment.
Patients and methods
From May 2002 to May 2010, 33 patients suffering from
persistent hyperinsulinemia hypoglycemia were admitted
to Mansoura university child hospital. Twenty patients
responded to medical treatment and 13 patients (eight
girls and five boys) were treated by near-total (90–95%)
pancreatectomy (Figs 1–4) after failure of medical
treatment. Their ages at the time of surgery ranged from
20 days to 27 months (mean age 6.8 ± 7.2 months).
The following laboratory investigations were conducted:
(1) complete blood profile,
(2) liver function tests,
(3) fasting blood glucose levels,
(4) blood gases,
(5) serum insulin levels in conjunction with blood
glucose levels,
(6) glucagon test.
Only patients who were surgically managed were included
in this study, as our aim was to evaluate the efficiency of
surgery in management of cases of PHHI after failure of
medical treatment.
All patients suffered from symptoms of PHHI (Table 1)
and were diagnosed following strict criteria that included
bouts of hypoglycemia under fasting conditions without
acidosis in association with increased insulin level as well
as positive response to 1 mg glucagon subcutaneously
(Table 2).
Medical treatment comprised somatostatin and nifedi-
pine for 2 weeks, as diazoxide is not routinely used
because of limited availability in Egypt.
Technique of surgery
The procedure is accomplished by a generous upper
transverse abdominal incision. Division of the gastrocolic
omentum and the lowest short gastric vessels affords an
excellent view of the whole pancreas. The uppermost
Fig. 1
Dissection of pancreas reaching the head.
Fig. 2
Near total pancreatectomy completed showing the superior mesenteric
and the splenic veins.
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short gastric vessels are preserved if possible without
compromising exposure. Following incision of the retro-
peritoneal investment of the gland along the inferior
surface, and division of the splenic peritoneal reflections,
complete mobilization and elevation of the spleen and
pancreas is possible along the avascular retropancreatic
plane. This facilitates careful bimanual palpation of the
gland. A Kocher maneuver allows inspection of the pan-
creatic head. If no nodule is palpated, near-total pan-
createctomy is undertaken. Dissection of the pancreas
from the splenic vessels was performed, meticulously
dividing all pancreatic branches using cautery and 6/0 silk
ligatures, starting at the tail and moving all the way to the
superior mesenteric vein and crossing it by dissecting the
uncinate process and most of the head, leaving only a
small remnant (B1 g) adjacent to the second part of the
duodenum.
Excision of the tail, body, uncinate process, and most of
the head of the pancreas was carried out ensuring that the
common bile duct was not injured and ligating the
pancreatic duct with nonabsorbable sutures.
Thus, 90–95% pancreatectomy was achieved.
All 13 pancreatic specimens were sent for postoperative
histological examination. However, intraoperative histo-
logical analysis was not attempted.
Strict control of blood sugar level between 100 and
200 mg/dl was achieved at the time of surgery and for days
thereafter using intravenous fluid and insulin early
through infusion at a rate ranging from 0.05 to 0.1 IU/
kg/h, then according to hourly blood sugar assessment
through the subcutaneous route.Insulin treatment was
needed only in those with early-onset diabetes mellitus.
Follow-up ranged from 3 months to 8 years.
Results
Thirteen patients (eight girls and five boys) were treated
by near-total pancreatectomy after failure of medical
treatment.
Primary success occurred in two cases (15%); 4 cases
(31%) developed temporary diabetes mellitus, and one
case (8%) had a temporary pancreatic fistula. Eventually,
total cure occurred in seven cases (54%).
The cases with primary success had no complications and
were euglycemic directly postoperatively and stayed that
way all through the follow-up. The patient who devel-
oped temporary diabetes and the patient who had tem-
porary pancreatic fistula eventually recovered completely
and were thus added to our number of successfully
treated patients, increasing the total number of success-
fully cured patients to seven.
Six cases (46%) developed a variety of complications:
hypoglycemia persisted in two cases, diabetes occurred in
three cases, one case showed developmental delay, two
cases showed persistent neurologic deficit, and one
unfortunately died (Table 3).
Fig. 3
The pancreatic duct ligated using nonabsorbable sutures.
Fig. 4
The excised specimen showing the head, body, tail, and uncinate
process.
Table 1 Symptoms at presentation










Table 2 Fasting blood sugar and concomitant serum insulin
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The earliest two patients showed persistent hypoglyce-
mia, which was controlled by medical treatment.
The three patients who developed diabetes were also
considered to be successful, as they were cured of PHHI.
One developed diabetes 10 days after surgery, whereas
the other two developed diabetes 2 or 3 months after
surgery, which was controlled by low-dose insulin. This
raised the success of the procedure to 10 cases (77%).
One patient died of sepsis that was unrelated to the
procedure.
To our dismay, all histological specimens were incon-
clusive and could not differentiate focal from diffuse
lesions.
Discussion
PHHI is the most common cause of refractory hypogly-
cemia during the first year of life. It is a rare condition
presenting with severe hypoglycemia. Prompt diagnosis
and early pancreatectomy can save many children, despite
the magnitude of surgery [17,18].
Timo Otonkoski and colleagues studied 14 patients with
PHHI and found that it is possible to identify the focal
forms of CHI using noninvasive fluorine-18-L-dihydroxy-
phenylalanine ([18F]-DOPA) PET. They found focal
accumulation of [18F]-DOPA in the pancreas of five
patients, and a focal lesion was confirmed histologically in
each case. All these infants underwent limited pancreatic
resection guided by perioperative biopsies, and all of
them have remained normoglycemic without treatment.
Diffuse pathology was confirmed in four of the nine
patients showing diffuse pancreatic accumulation of
[18F]-DOPA and were treated by near-total pancreatic
resection [19].
We did not have the luxury of using invasive and
technically demanding techniques based on pancreatic
venous sampling or pancreatic arterial calcium stimula-
tion or [18F]-DOPA PET in our study. This was because
of the nonavailability of these techniques in our estab-
lishment, which made it impossible for us to preopera-
tively differentiate focal from diffuse forms. All our
postoperative specimens were sent for histological ex-
amination but were not conclusive because of lack of
experience among our pathologists.
The study by Al-Nassar and colleagues, a long-term retro-
spective study in which 43 Saudi children with PHHI,
has been followed up since 1983. The patients were
severely hypoglycemic and intolerant to fasting. Hypogly-
cemic convulsion was the most commonly presenting
complaint. Eighteen patients were developmentally delayed
and 14 of them had brain atrophy. All patients, except nine,
did not respond to medical treatment and underwent
surgery. Four pancreatectomized patients developed dia-
betes and two had malabsorption [20].
In our series 13 of 33 patients were managed surgically,
which is a larger number than that in the study by Al-
Nassar and colleagues, and we also showed a lower
incidence of complications. This in our opinion is related
to our early decision to operate upon patients who did not
respond to medical treatment.
Meissner and colleagues conducted a large long-term
cohort study on 114 CHI patients from different hos-
pitals, the results of which were obtained using a detailed
questionnaire. Patients presented neonatally (65%), dur-
ing infancy (28%), or during childhood (7%). They observed
a high rate of pancreatic surgery in the neonatal-onset group
(70%) compared with the infancy/childhood-onset group
(28%). Partial (3%), subtotal (37%), or near-total (15%)
pancreatectomy was performed. After pancreatic surgery
there appeared a high risk of persistent hypoglycemia
(40%). Immediately after surgery or with a latency of sev-
eral years insulin-dependent diabetes mellitus was observed
in patients operated upon (27%). General outcome was
poor with a high degree of psychomotor or mental retar-
dation (44%) or epilepsy (25%). An unfavorable outcome
was correlated with infancy-onset manifestation (P = 0.01)
[21].
We believe that near-total pancreatectomy gives optimal
results for control of PHHI and that the results of
Meissner and colleagues would have been much better if
they had used this procedure in all patients.
Further, Lovvorn and colleagues found in his retrospec-
tive study on 101 children treated between 1963 and
1998 for congenital hyperinsulinism, and who required
pancreatectomy, that subtotal (< 95%) or near-total
(95–98%) pancreatectomy had been performed for gly-
cemic control in babies who did not respond to aggressive
medical therapy. They recommended that because eugly-
cemia is more readily restored, and because the risks for
surgical complications and diabetes mellitus do not appear
increased, 95% pancreatectomy be the initial procedure
of choice for newborns and infants with congenital
hyperinsulinism [22].
The results of the above study were found to be in total
agreement with those of our series.
Al-Shanafey and colleagues managed 12 patients diag-
nosed with PHHI by laparoscopic 90% pancreatectomy.
There were two (16%) conversions to an open technique.
One patient required reoperation 3 months after the
procedure. Four (33%) were euglycemic with no medica-
tions. Three patients remained on octreotide postopera-
tively to be euglycemic, and three patients needed a
combination of octreotide and diazoxide. One patient
remained euglycemic for 10 months and was then started
on octreotide because of recurrence of hypoglycemia.
One patient remained hypoglycemic postoperatively and
required reoperation 3 months later to control symptoms.
Table 3 Postoperative complications
Complication N
Persistent hypoglycemia 2
Persistent diabetes mellitus 3
Developmental delay 1
Persistent neurological deficit 2
Mortality 1
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He became diabetic 4 months after reoperation and was
prescribed insulin. These data proved that laparoscopic
pancreatectomy was feasible and safe [23].
In our study, we did not attempt laparoscopic pancrea-
tectomy but we also believe that it is feasible and safe in
experienced hands, however expensive.
We hope that in the future we would be able to apply
advanced investigations and accurate histological exam-
ination as we try to make them available at our facility. We
believe that these would lead to better and more accurate
management of patients with PHHI.
Conclusion
Near-total (90–95%) pancreatectomy is a suitable proce-
dure for treatment of patients with nesidioblastosis not
responding to medical treatment and should be per-
formed as early as possible.
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